Transurethral intraprostatic Botulinum toxin-A injection: a novel treatment for BPH refractory to current medical therapy in poor surgical candidates

The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia

John D. McConnell, Reginald C. Bruskewitz, Patrick Walsh et al. · New England Journal of Medicine · 1998 · 1.1K citations · Full text

AUA Guideline on Management of Benign Prostatic Hyperplasia (2003). Chapter 1: Diagnosis and Treatment Recommendations

The Journal of Urology · 2003 · 843 citations

The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic Hyperplasia

Herbert Lepor, William O. Williford, Michael J. Barry et al. · New England Journal of Medicine · 1996 · 796 citations · Full text

Regulated Exocytosis Contributes to Protein Kinase C Potentiation of Vanilloid Receptor Activity

Cruz Morenilla‐Palao, Rosa Planells‐Cases, Nuria García‐Sanz et al. · Journal of Biological Chemistry · 2004 · 425 citations · Full text

Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study

Giorgio Maria, Giuseppe Brisinda, Ignazio Massimo Civello et al. · Urology · 2003 · 229 citations

Urology, Voiding Dysfunction, Botulinum Toxin +5